Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Canada Drug-Coated Balloons Market: By Indication, By Drug Type, By End-user
Canada Drug-Coated Balloons Market: By Indication, By Drug Type, By End-user
Canada Drug-Coated Balloons Market size was valued at US$ million in 2023. It is expected to reach US$ million by 2030, growing at a CAGR of 11.9% from 2024 to 2030. The market report provides a detailed overview of the market, which can be segmented by indication, drug type, and end-user. By indication, the Canadian drug-coated balloons market has been segmented into PAD, CAD, and others. The PAD segment is likely the most significant and fastest-growing segment regarding VARIOUS indications. The Canada drug-coated balloons market has been segmented by drug type into Paclitaxel and Sirolimus. The Paclitaxel segment accounted for the high revenue share in 2021. Based on end-user, the Canadian drug-coated balloons market is segmented into Hospitals, Ambulatory Care Settings, and Freestanding Cath Labs. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.
A primary reason driving the drug-eluting balloons market is the increased incidence of cardiovascular, peripheral vascular, and neurovascular illnesses.
|
Report Benchmarks |
Details |
|
By Indication |
|
|
By Drug Type |
|
|
By End User |
|
Download Free Sample Report
The canada drug-coated balloons market is projected to expand at a CAGR of 11.9% during the forecast period.
The major players in the Canada drug-coated balloons market are ??? Medtronic, Koninklijke Philips, BD, B. Braun Melsungen, Biosensors International Group, Boston Scientific, MedAlliance, and BioMed.
| 1. Canada Drug-Coated Balloons Market Introduction |
| 1.1. Canada Drug-Coated Balloons Market Taxonomy |
| 1.2. Canada Drug-Coated Balloons Market Definitions |
| 1.2.1. By Indication |
| 1.2.2. By Drug Type |
| 1.2.3. By End User |
| 2. Canada Drug-Coated Balloons Market Dynamics |
| 2.1. Drivers |
| 2.2. Restraints |
| 2.3. Opportunities/Unmet Needs of the Market |
| 2.4. Trends |
| 2.5. Canada Drug-Coated Balloons Market Dynamic Factors - Impact Analysis |
| 2.6. Canada Drug-Coated Balloons Market Competition Landscape |
| 3. Canada Drug-Coated Balloons Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 |
| 3.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 3.3. Market Opportunity Analysis |
| 4. Canada Drug-Coated Balloons Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.1. PAD |
| 4.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.1.3. Market Opportunity Analysis |
| 4.2. CAD |
| 4.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.2.3. Market Opportunity Analysis |
| 4.3. Others |
| 4.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 4.3.3. Market Opportunity Analysis |
| 5. Canada Drug-Coated Balloons Market Forecast, By Drug Type, 2019 - 2023 and Forecast, 2022 2028 (Revenue, USD Mn)Â |
| 5.1. Paclitaxel |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Sirolimus |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Canada Drug-Coated Balloons Market Forecast, By End User, 2019 - 2023 and Forecast, 2022 2028 (Revenue, USD Mn)Â |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Care Settings |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Freestanding Cath Labs |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Competition Landscape |
| 7.1. Strategic Dashboard of Top Market Players |
| 7.2. Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 7.2.1. Medtronic |
| 7.2.2. Koninklijke Philips |
| 7.2.3. BD |
| 7.2.4. B. Braun Melsungen |
| 7.2.5. Biosensors International Group |
| 7.2.6. Boston Scientific |
| 7.2.7. MedAlliance |
| 7.2.8. BioMed |
| 8. Research Methodology |
| 9. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.